Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Accumulated Expenses (2020 - 2023)

Terns Pharmaceuticals' Other Accumulated Expenses history spans 4 years, with the latest figure at $392000.0 for Q3 2023.

  • For Q3 2023, Other Accumulated Expenses rose 27.27% year-over-year to $392000.0; the TTM value through Sep 2023 reached $392000.0, up 27.27%, while the annual FY2022 figure was $185000.0, 48.32% down from the prior year.
  • Other Accumulated Expenses reached $392000.0 in Q3 2023 per TERN's latest filing, up from $280000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $392000.0 in Q3 2023 to a low of $83000.0 in Q1 2021.
  • Average Other Accumulated Expenses over 4 years is $230416.7, with a median of $228000.0 recorded in 2022.
  • The largest YoY upside for Other Accumulated Expenses was 271.08% in 2022 against a maximum downside of 48.32% in 2022.
  • A 4-year view of Other Accumulated Expenses shows it stood at $162000.0 in 2020, then surged by 120.99% to $358000.0 in 2021, then crashed by 48.32% to $185000.0 in 2022, then soared by 111.89% to $392000.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Other Accumulated Expenses are $392000.0 (Q3 2023), $280000.0 (Q2 2023), and $363000.0 (Q1 2023).